Authors: | Fury, M. G.; Shah, J. P. |
Article Title: | Induction chemotherapy in the management of head and neck cancer |
Abstract: | The strategy of induction chemotherapy prior to planned definitive local therapy for head and neck squamous cell carcinoma has been studied for over 30 years, and appears to have a role in select clinical situations. Here we review landmark studies regarding induction chemotherapy, both in the pre-taxane era and in the current taxane era, and we address some of the unresolved questions regarding the role of induction chemotherapy in head and neck cancer. © 2010 Wiley-Liss, Inc. |
Keywords: | cancer chemotherapy; cancer survival; treatment response; cancer surgery; clinical trial; drug tolerability; review; larynx carcinoma; squamous cell carcinoma; carcinoma, squamous cell; cisplatin; fluorouracil; drug efficacy; patient selection; treatment planning; antineoplastic agents; paclitaxel; cancer radiotherapy; chemotherapy, adjuvant; neoadjuvant therapy; cancer staging; carboplatin; multiple cycle treatment; nephrotoxicity; bone marrow suppression; cetuximab; docetaxel; febrile neutropenia; rash; add on therapy; head and neck cancer; head and neck neoplasms; bleomycin; nausea and vomiting; oropharynx cancer; organ preservation; medical literature; taxoids; taxane derivative; drug substitution; larynx cancer; everolimus; mouth cancer; oropharynx carcinoma; induction chemotherapy; hypopharynx cancer; bridged compounds |
Journal Title: | Journal of Surgical Oncology |
Volume: | 101 |
Issue: | 4 |
ISSN: | 0022-4790 |
Publisher: | Wiley Blackwell |
Date Published: | 2010-03-15 |
Start Page: | 292 |
End Page: | 298 |
Language: | English |
DOI: | 10.1002/jso.21438 |
PUBMED: | 20187068 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | --- - "Export Date: 20 April 2011" - "CODEN: JSONA" - "Source: Scopus" |